In early May 2023, the "7th Future Medical 100 Power Conference" hosted by VB100, VB Data and VCBeat Research and supported by strategic cooperation of Shanghai Zhangjiang Group was grandly held in Shanghai Zhangjiang Science Hall with the theme of "Bu Wen Xi Dong". At the meeting, the 7th Future Medical Top 100 List in 2023 was released, and Hopstem has successfully listed on the "2023 Future Medical Top 100 - Top 100 Chinese Innovative Biomedicine List" with its accumulated experience, achievements, growth and development potential in the field of iPSC cell therapy.

Hopstem stood out from thousands of companies through layers of selection and was listed on the "Top 100 of China's Innovative Pharmaceutical List", which shows that the fully affirms from the industry about the comprehensive strength and the growth potential of Hopstem biotechnology.